BBA-Health is dedicated to creating disruptive technologies and solutions in the neuropsychiatric field. Building upon years of clinical research and scientific development using quantitative electroencephalography (qEEG) to monitor the brain activity of patients suffering from depression, BBA-Health is developing innovative tools for physicians to use in the battle against depression.  These tools will change the entire paradigm for how depression is managed, ultimately having the potential to reduce the suffering of millions of people who deal with depression every day.


Changing the paradigm of depression treatment